Edition:
United States

Insider Trading: aTyr Pharma Inc (LIFE.OQ)

LIFE.OQ on NASDAQ Stock Exchange Global Select Market

3.55USD
17 Feb 2017
Change (% chg)

$0.10 (+2.90%)
Prev Close
$3.45
Open
$3.50
Day's High
$3.55
Day's Low
$3.50
Volume
2,400
Avg. Vol
27,421
52-wk High
$6.32
52-wk Low
$2.12

RICHARD KELLI

Institutional Holders

% Shares Owned: 80.57%
# of Holders: 62
Total Shares Held: 19,110,857
3 Mo. Net Change: 243,484
# New Positions: 13
# Closed Positions: 7
# Increased Positions: 25
# Reduced Positions: 20
# Net Buyers: 5

Officers & Directors

Name Age Since Current Position

John Mendlein

56 2011 Chief Executive Officer and Executive Chairman, Board of Directors

John Clarke

62 2005 Non-Executive Independent Chairman of the Board

John Blake

39 2016 Principal Financial Officer, Chief Accounting Officer

David King

2016 Senior Vice President - Research

Melissa Ashlock

57 2011 Vice President - External Scientific Alliances and Human Genetics

Holly Chrzanowski

49 2013 Vice President - Enterprise Talent and Organization

Andrew Cubitt

52 2011 Vice President - Product Protection

John McKew

51 2014 Vice President - Research

Fred Ramsdell

54 2014 Vice President - Immunology

Sanuj Ravindran

2016 Chief Business Officer

Sanjay Shukla

2016 Chief Medical Officer

Srinivas Akkaraju

48 2015 Non-Executive Independent Director

James Blair

76 2010 Non-Executive Independent Director

Kathryn Falberg

55 2014 Non-Executive Independent Director

Mark Goldberg

61 2015 Non-Executive Independent Director

Amir Nashat

38 2006 Non-Executive Independent Director

Paul Schimmel

75 2005 Non-Executive Independent Director